Not Signed In -
Cetuximab |
Erbitux |
Image:Cetuximab.png Cetuximab Systematic (IUPAC) name Humanized anti-EGF receptor (EGFr) antibody Identifiers CAS number 205923-56-4 ATC code ? PubChem ? DrugBank BTD00071 Chemical data Formula C6484H10042N1732O2023S36 Mol. weight 145781.6 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life 114 hrs Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? Cetuximab (Erbitu ...
Wikipedia - [full article]
Cetuximab News Headlines
- Novel EGFR Antibody Outperforms Cetuximab In Mouse Model Of Lung Cancer
MedicalNewsToday - Wed, 31 Jan 2007 02:00 EST
- Potential Solution To Cetuximab-resistance In Lung Cancers Found In Novel EGFR Antibody
ScienceDaily - Fri, 26 Jan 2007 04:00 EST
- MClone Systems Incorporated And Bristol-Myers Squibb Announce Application In Japan For Use Of ERBITUX In Metastatic Colorectal Cancer
MedicalNewsToday - Sun, 11 Feb 2007 08:00 EST
- Cetuximab With Radiotherapy Does Not Increase Side Effects For Head And Neck Cancer Patients
MedicalNewsToday - Fri, 19 Jan 2007 08:00 EST
- Cetuximab May Prolong Survival For Head And Neck Cancer Patients
MedicalNewsToday - Fri, 19 Jan 2007 08:00 EST
- New Drug May Help Prolong Survival For Head And Neck Cancer Patients
ScienceDaily - Fri, 19 Jan 2007 04:00 EST
- ERBITUX® Phase III Study Meets Primary Endpoint In First-Line Treatment Of Metastatic Colorectal Cancer
MedicalNewsToday - Mon, 15 Jan 2007 08:00 EST
- Survival Data Available From Two Randomized ERBITUX Studies In Metastatic Colorectal Cancer
MedicalNewsToday - Tue, 07 Nov 2006 08:00 EST
- Welcome New Treatment For Head And Neck Cancer Patients In Scotland, Says Cancerbackup
MedicalNewsToday - Mon, 17 Jul 2006 06:00 EST
- UK Is Only European Country Denying Access To Erbitux - Colorectal Cancer Drug
MedicalNewsToday - Sat, 15 Jul 2006 06:00 EST
- FDA Approves ERBITUX(R) (Cetuximab) For Treatment Of Head And Neck Cancer
MedicalNewsToday - Thu, 02 Mar 2006 03:00 EST
- FDA Approves First Head & Neck Cancer Treatment In 45 Years Data Shows Treatment With Erbitux Extends Survival
MedicalNewsToday - Fri, 10 Mar 2006 11:00 EST
- Treatments have same target, different responses for lung cancer patients with genetic mutation
MedicalNewsToday - Thu, 18 Aug 2005 02:00 EST
- Study Shows Erbitux May Fight Colorectal Cancer After Other Therapies Fail
ScienceDaily - Wed, 18 May 2005 03:00 EST
- Head And Neck Cancer - Amended Timeline For Erbitux® Supplemental Biologics License Application Filing
MedicalNewsToday - Sun, 17 Apr 2005 06:00 EST
email this page
print this page
bookmark this page
feedback on this page
